Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease

N Engl J Med. 2026 Jul 16;395(3):233-242. doi: 10.1056/NEJMoa2517588.ABSTRACTBACKGROUND: Patients with multivessel coronary artery disease often receive 12 months of dual antiplatelet therapy (DAPT) after stenting to reduce the risk of ischemic events. Whether extending DAPT beyond 12 months in even

J Jinwei Tian

Integrating Human-AI Collaboration in ECG Analysis for Clinical Advancement

NEJM Catal Innov Care Deliv. 2026;7(s1):CAT250256. doi: 10.1056/CAT.25.0256. Epub 2026 Mar 18.ABSTRACTElectrocardiogram (ECG) interpretation is fundamental to cardiovascular care, yet persistent human variability and escalating diagnostic demands hinder its reliability and scalability. Despite the r

X Xiaolin Diao

Biomarkers in predicting mortality in hemodialysis patients: recent advances

Pol Arch Intern Med. 2026 Jul 15:17351. doi: 10.20452/pamw.17351. Online ahead of print.ABSTRACTPatients undergoing maintenance hemodialysis face annual mortality rates of 15-27%, with cardiovascular causes accounting for more than half of all deaths. Despite advances in dialytic technology, convent

D Davide Ramoni

Exercise training for cardiovascular prevention in patients with cancer

Eur Heart J. 2026 Jul 15:ehag089. doi: 10.1093/eurheartj/ehag089. Online ahead of print.ABSTRACTPatients with cancer usually report limitations of their functional capacity, which may range from subclinical impairment of cardiopulmonary exercise reserve to poor quality of life with physical, cogniti

M Massimo Piepoli